Fabrication and Characterization of Fast-Dissolving Films Containing Escitalopram/Quetiapine for the Treatment of Major Depressive Disorder

Major depressive disorder (MMD) is a leading cause of disability worldwide. Approximately one-third of patients with MDD fail to achieve response or remission leading to treatment-resistant depression (TRD). One of the psychopharmacological strategies to overcome TRD is using a combination of an ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkahtani, Manal E., Aodah, Alhassan H., Abu Asab, Omar A., Basit, Abdul W., Orlu, Mine, Tawfik, Essam A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234593/
https://www.ncbi.nlm.nih.gov/pubmed/34208460
http://dx.doi.org/10.3390/pharmaceutics13060891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234593/
https://www.ncbi.nlm.nih.gov/pubmed/34208460
http://dx.doi.org/10.3390/pharmaceutics13060891

Ejemplares similares